Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
January 29, 2026
Made to last: engineering durable CAR-T cells
From the Peterson and Kiem Labs, Translational Science and Therapeutics Division
Engineering B cells to improve HIV treatments
From the Kiem lab, Translational Sciences and Therapeutics Division
Two Fred Hutch students receive American Society for Hematology graduate awards
The two-year, $40,000 annual awards support emerging researchers studying myelodysplastic syndromes and pediatric leukemia
Scientists see foam as starting point of a path to bedside gene therapy
Bioengineer Dr. Matthias Stephan developed a quick-foaming solution that he hopes could one day turn gene therapy into an outpatient procedure
Stealing a base from cancer: precision editing for safer immunotherapy
From the Kiem Lab, Translational Science and Therapeutics Division
Fred Hutch Cancer Center announces 2025 Evergreen Fund awardees
Nine Fred Hutch researchers receive funding totaling $1.175 million for projects with commercial partnership potential
Gene therapy delivery system successfully targets CD90+ hematopoietic stem cells in vivo
Fred Hutch laboratory research presented at the American Society of Gene and Cell Therapy’s annual meeting moves a promising approach one step closer to clinical trials
Towards accessible gene therapy: in vivo base editing to cure Sickle Cell Disease
From the Cancer Consortium Lieber Lab, Department of Laboratory Medicine and Pathology, University of Washington
Dr. Hans-Peter Kiem awarded amfAR grant for research on HIV gene therapy
Potential cure builds on unexpected findings about hematopoietic stem cells
Hitting ‘undo’ to cure Sickle Cell Disease
From the Lieber and Kiem Labs, Hematologic Malignancies Program, Cancer Consortium.
Eight Fred Hutch teams win Evergreen Fund awards
Research projects with commercial partnership potential receive grants of up to $200K
Fred Hutch hosts inaugural Dr. E. Donnall Thomas Symposium
Event draws leading researchers in transplantation, gene and cell therapy
The future of blood stem cell gene therapy is in vivo
From the Lieber and Kiem Labs, Hematologic Malignancies Program, Cancer Consortium.
Testing cord blood transplants as a cure for leukemia — and HIV
New clinical trial at several U.S. cancer centers will enroll people living with HIV and advanced leukemia
AIDS@40: Stories of hope and heroes
The people and the science devoted to stopping HIV
Location, location, location: therapeutic T cells traffic to HIV reservoirs
From the Kiem Lab, Clinical Research Division
Tip Sheet: Diversity in vaccine clinical trials, behind-the-scenes look at COVID-19 biostats, new cell therapy approved, plus meet ‘Megasphaera hutchinsoni’
Summaries of recent Fred Hutch research findings and other news
Hutch research helps launch new genomic medicine company
Ensoma receives $70 million in financing to develop genome modification technologies via a single injection